An interventional study of Gingko Biloba in Healthy, sponsored by State University of New York College of Optometry. Completed at 1 site in United States. Open to participants aged 20 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-10-24.
Sponsored by State University of New York College of Optometry · Not applicable, Interventional, and Basic science
The purpose of this study is to understand the effect of Ginkgo Biloba oral supplements on retinal and choroidal ocular tissue.
The study objectives are to:
State University of New York College of Optometry is the lead sponsor of 17 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
oral intake of gingko biloba for 4 weeks
Dietary Supplement: Gingko Biloba
oral intake of Gingko Biloba, 240mg/day for 4 weeks
ocular blood flow
ocular blood flow measured with doppler ultrasound
Time frame: 4 weeks
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Oct 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
State University of New York College of Optometry